1. Home
  2. STKH vs LIXT Comparison

STKH vs LIXT Comparison

Compare STKH & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • LIXT
  • Stock Information
  • Founded
  • STKH 2018
  • LIXT 2005
  • Country
  • STKH Israel
  • LIXT United States
  • Employees
  • STKH N/A
  • LIXT N/A
  • Industry
  • STKH Packaged Foods
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • LIXT Health Care
  • Exchange
  • STKH Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • STKH 4.6M
  • LIXT 4.1M
  • IPO Year
  • STKH 2021
  • LIXT N/A
  • Fundamental
  • Price
  • STKH $1.60
  • LIXT $2.33
  • Analyst Decision
  • STKH
  • LIXT
  • Analyst Count
  • STKH 0
  • LIXT 0
  • Target Price
  • STKH N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • STKH 41.5K
  • LIXT 18.9K
  • Earning Date
  • STKH 08-30-2024
  • LIXT 11-12-2024
  • Dividend Yield
  • STKH N/A
  • LIXT N/A
  • EPS Growth
  • STKH N/A
  • LIXT N/A
  • EPS
  • STKH N/A
  • LIXT N/A
  • Revenue
  • STKH N/A
  • LIXT N/A
  • Revenue This Year
  • STKH N/A
  • LIXT N/A
  • Revenue Next Year
  • STKH N/A
  • LIXT N/A
  • P/E Ratio
  • STKH N/A
  • LIXT N/A
  • Revenue Growth
  • STKH N/A
  • LIXT N/A
  • 52 Week Low
  • STKH $1.43
  • LIXT $1.31
  • 52 Week High
  • STKH $7.70
  • LIXT $4.40
  • Technical
  • Relative Strength Index (RSI)
  • STKH 40.05
  • LIXT 54.46
  • Support Level
  • STKH $1.50
  • LIXT $2.25
  • Resistance Level
  • STKH $1.70
  • LIXT $2.68
  • Average True Range (ATR)
  • STKH 0.16
  • LIXT 0.23
  • MACD
  • STKH 0.02
  • LIXT 0.01
  • Stochastic Oscillator
  • STKH 38.89
  • LIXT 53.90

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is a deep-tech food company. The company is cultivating meat technologies to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. The company aims to provide an alternative to industrialized animal farming that reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. It is developing a novel, proprietary three-dimensional bioprinter for three-dimensional printing of meat and seafood analogs, followed by hybrid meats that combine cultivated and plant-based elements.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: